Neoplasia/BPH

	A diagnostic pitfall in suspected giant cell arteritis: metastatic renal cell carcinoma mimicking the temporal artery halo sign on ultrasound. Rheumatol Int Yamancan G, Karata. PMID: 42384226 [PubMed - in process]
	Diagnostic performance of PI-RADS and PSA density for detecting clinically significant prostate cancer. Arch Ital Urol Androl Shanaa W, Alnadhari I, Ali O, Abdeljaleel O, Abukhadijah HJ, Shamsodini A. PMID: 42383731 [PubMed - indexed for MEDLINE]
	The relationship of prostate cancer diagnosed by magnetic resonance imaging/transrectal ultrasound prostate fusion biopsy with standard and adjusted anogenital distances. Arch Ital Urol Androl Sinan Erdal F, Erbin A, Sekkeli S, Dizdaroglu C, Turkay R. PMID: 42383730 [PubMed - indexed for MEDLINE]
	Cost efficiency of ERAS protocols versus conventional method in urologic oncology: a systematic review of economic evaluations. Arch Ital Urol Androl Yanda A, Ismy J, Mauny MP, Khalilullah SA, Hidayatullah F. PMID: 42383727 [PubMed - indexed for MEDLINE]
	Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study. Front Immunol Wang C, He S, Li D, Zhang B, Dai Y, Li C, Li X, Kang L, Yang S, Zhang S, Fan N, Chang H, Wu G, Yue Z, Ma J, Shang P. PMID: 42382757 [PubMed - indexed for MEDLINE]
	Irreversible electroporation in focal therapy for prostate cancer: current status and future directions. Prostate Int Durazo-Ruiz FO, Roldán-Testillano R, Rodriguez-Sanchez L, Laguna MP, Mendez-Bisgaard LN, Arezki A, Elkhatib H, Hevia-Feliu A, Zhang K, Fainberg J, Perlis N, Rosette J, Miñana-López B, de Reijke TM, Anidjar M, Emberton M, Stricker PD, Sanchez-Salas R. PMID: 42382550 [PubMed]
	Therapeutic potentials of curcumin in prostate cancer: a comprehensive review of pathways and clinical prospects. Prostate Int Fattahi MR, Shoja F, Mojaradi MA, Nazarinezhad P, Dehghanbanadaki H, Arefnezhad R, Rezaei-Tazangi F, Azimi H. PMID: 42382546 [PubMed]
	Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Adv Radiat Oncol Nohmi RL, Marques FC, Brito HC, Leite LM, Araujo DV. PMID: 42382432 [PubMed]
	Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: A Retrospective Study. Indian J Surg Oncol Abouzid A, Shetiwy M, Hamdy M, Atallah K, Ezzat M, Elghaffar MA. PMID: 42381807 [PubMed]
	Correlation of Multiparametric MRI PIRADS Scoring with Histopathological Outcomes and Prognostic Significance in Prostate Cancer: A Tertiary Care Center Study. Indian J Surg Oncol R KJ, Charan NS, Ram CG, Mahendra S, Deepak B, S SA, Taruna Y, Meenakshi R. PMID: 42381792 [PubMed]
	Cardiovascular-Kidney-Metabolic Syndrome, Healthy Lifestyles, and Risk of Cancer Incidence and Mortality: AÂ Prospective Cohort Study. Int J Cancer Qie R, Liu H, Liu Y, Guo X, Chen Q, Xu H, Wang X, Kang R, Cheng C, Zhao M, Wang H, Zheng L, Liu S, Zhang S. PMID: 42381231 [PubMed - as supplied by publisher]
	Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis. BMC Med Wu JL, Jiang SS, Luo H, Dong P, Wang ZJ, Xing NZ, Ma T, Wang ZP, Gu XQ, Zhou GC, Xue XY, Sun ZQ, Yang Y, Wang CX, Shan GY, Zhang AL, Ding DG, Wang LP, Duan XH, Wang TT, He T, Lin CY, Zhong XW, Lian JP, Wang WL, Ye DW, Dai B. PMID: 42380973 [PubMed - as supplied by publisher]
	Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know. Abdom Radiol (NY) Takahashi S, Miura M, Higashiyama H. PMID: 42380349 [PubMed - as supplied by publisher]
	Re: Ultra-hypofractionated Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma: 5-year Outcomes from a Pooled Analysis of the FASTRACK Trials. Eur Urol Liu T, Zhu C, Yan Z. PMID: 42379927 [PubMed - as supplied by publisher]
	Re: Alexander D. Sherry, Van To, Criselle D'souza, et al. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.03.024. Eur Urol Cigliola A, Necchi A, Capitanio U. PMID: 42379926 [PubMed - as supplied by publisher]
	Ureteral Orifice Stricture After Transurethral Resection of Bladder Tumors Involving the Ureteral Orifice or Adjacent Area: Clinical Course and Outcomes. In Vivo Shiraishi Y, Furubayashi N, Tsujita J, Takayama A, Kojima T, Nakano Y, Kataoka A, Nakamura M, Negishi T. PMID: 42379772 [PubMed - indexed for MEDLINE]
	Real-world Implementation of Adjuvant Pembrolizumab for High-risk Clear-cell Renal Cell Carcinoma After Surgery. In Vivo Furubayashi N, Kojima T, Nakano Y, Kataoka A, Nakamura M, Negishi T. PMID: 42379743 [PubMed - indexed for MEDLINE]
	Beyond the tumor: Recurrence-prone radiomics for prognostication in negative PSMA PET/CT scans of prostate cancer. Biomed Phys Eng Express Yousefirizi F, Harsini S, Mohebi M, Alberts I, Yusufaly T, Luo M, Abdollahi H, Yazdani E, Mirabedian S, Sabouri M, Geramifar P, Sheikhzadeh P, Martineau P, Wilson D, Bénard F, Uribe CF, Rahmim A. PMID: 42379193 [PubMed - as supplied by publisher]
	Clinically relevant endpoints and quality-of-life outcomes with darolutamide in patients with metastatic hormone-sensitive prostate cancer: Analyses of the phase III ARASENS trial. Eur J Cancer Fizazi K, Smith MR, Hussain M, Saad F, Sternberg CN, David Crawford E, Aragon-Ching JB, Schostak M, Tutrone R, Morgans AK, Sentana-Lledo D, Joensuu H, Mohamed AF, Littleton N, Srinivasan S, Buttkewitz Y, Li R, Kuss I, Tombal B. PMID: 42378957 [PubMed - as supplied by publisher]
	Pulmonary Tuberculosis following Chemotherapy for Metastatic Testicular Germ Cell Tumor: Possible Reactivation of Latent Tuberculosis Infection. Int J Mycobacteriol Ramadhan DS, Marhana IA. PMID: 42378617 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 189330

Page 1 of 9467



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy